chr7-21588619-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001277115.2(DNAH11):​c.1956C>T​(p.Phe652Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.989 in 1,613,386 control chromosomes in the GnomAD database, including 788,992 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.99 ( 74936 hom., cov: 32)
Exomes 𝑓: 0.99 ( 714056 hom. )

Consequence

DNAH11
NM_001277115.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.238

Publications

16 publications found
Variant links:
Genes affected
DNAH11 (HGNC:2942): (dynein axonemal heavy chain 11) This gene encodes a ciliary outer dynein arm protein and is a member of the dynein heavy chain family. It is a microtubule-dependent motor ATPase and has been reported to be involved in the movement of respiratory cilia. Mutations in this gene have been implicated in causing Kartagener Syndrome (a combination of situs inversus totalis and Primary Ciliary Dyskinesia (PCD), also called Immotile Cilia Syndrome 1 (ICS1)) and male sterility. [provided by RefSeq, Mar 2013]
DNAH11 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 7
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), ClinGen
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 7-21588619-C-T is Benign according to our data. Variant chr7-21588619-C-T is described in ClinVar as Benign. ClinVar VariationId is 163097.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.238 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.989 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH11NM_001277115.2 linkc.1956C>T p.Phe652Phe synonymous_variant Exon 11 of 82 ENST00000409508.8 NP_001264044.1 Q96DT5Q96NT7H9NAJ8H9NAJ7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH11ENST00000409508.8 linkc.1956C>T p.Phe652Phe synonymous_variant Exon 11 of 82 5 NM_001277115.2 ENSP00000475939.1 Q96DT5

Frequencies

GnomAD3 genomes
AF:
0.992
AC:
150956
AN:
152188
Hom.:
74876
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.997
Gnomad AMI
AF:
0.996
Gnomad AMR
AF:
0.991
Gnomad ASJ
AF:
0.988
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
0.981
Gnomad FIN
AF:
0.999
Gnomad MID
AF:
0.984
Gnomad NFE
AF:
0.989
Gnomad OTH
AF:
0.986
GnomAD2 exomes
AF:
0.991
AC:
246596
AN:
248948
AF XY:
0.990
show subpopulations
Gnomad AFR exome
AF:
0.997
Gnomad AMR exome
AF:
0.993
Gnomad ASJ exome
AF:
0.986
Gnomad EAS exome
AF:
1.00
Gnomad FIN exome
AF:
0.997
Gnomad NFE exome
AF:
0.989
Gnomad OTH exome
AF:
0.988
GnomAD4 exome
AF:
0.989
AC:
1444439
AN:
1461080
Hom.:
714056
Cov.:
48
AF XY:
0.988
AC XY:
718304
AN XY:
726862
show subpopulations
African (AFR)
AF:
0.997
AC:
33374
AN:
33462
American (AMR)
AF:
0.993
AC:
44412
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.987
AC:
25790
AN:
26128
East Asian (EAS)
AF:
1.00
AC:
39669
AN:
39672
South Asian (SAS)
AF:
0.983
AC:
84787
AN:
86240
European-Finnish (FIN)
AF:
0.997
AC:
53206
AN:
53374
Middle Eastern (MID)
AF:
0.976
AC:
5630
AN:
5766
European-Non Finnish (NFE)
AF:
0.988
AC:
1097911
AN:
1111366
Other (OTH)
AF:
0.989
AC:
59660
AN:
60354
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.449
Heterozygous variant carriers
0
820
1640
2461
3281
4101
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21656
43312
64968
86624
108280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.992
AC:
151076
AN:
152306
Hom.:
74936
Cov.:
32
AF XY:
0.992
AC XY:
73899
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.997
AC:
41446
AN:
41570
American (AMR)
AF:
0.991
AC:
15152
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.988
AC:
3429
AN:
3472
East Asian (EAS)
AF:
1.00
AC:
5178
AN:
5178
South Asian (SAS)
AF:
0.982
AC:
4733
AN:
4822
European-Finnish (FIN)
AF:
0.999
AC:
10605
AN:
10618
Middle Eastern (MID)
AF:
0.980
AC:
288
AN:
294
European-Non Finnish (NFE)
AF:
0.989
AC:
67253
AN:
68034
Other (OTH)
AF:
0.986
AC:
2084
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
63
125
188
250
313
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
914
1828
2742
3656
4570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.989
Hom.:
159515
Bravo
AF:
0.992
Asia WGS
AF:
0.992
AC:
3449
AN:
3478
EpiCase
AF:
0.986
EpiControl
AF:
0.985

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Phe652Phe in exon 11 of DNAH11: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue and is not located wi thin the splice consensus sequence. It has been identified in 1.3% (108/8220) of European American chromosomes from a broad population by the NHLBI Exome Sequen cing Project (http://evs.gs.washington.edu/EVS; dbSNP rs6963535). -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia 7 Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Dec 19, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.49
CADD
Benign
2.8
DANN
Benign
0.46
PhyloP100
-0.24
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6963535; hg19: chr7-21628237; COSMIC: COSV108124251; API